Skip to main
DXCM

DexCom (DXCM) Stock Forecast & Price Target

DexCom (DXCM) Analyst Ratings

Based on 21 analyst ratings
Buy
Strong Buy 48%
Buy 38%
Hold 10%
Sell 5%
Strong Sell 0%

Bulls say

DexCom is a leader in the diabetes device sector, with its CGM systems offering a more advanced and convenient alternative to traditional glucose monitoring methods. The company has a strong focus on innovation, with plans to integrate its technology with insulin pumps and develop adjacent software solutions. With strong financials and steady growth projections, DexCom is well-positioned for continued success in the diabetes market, making it a compelling investment opportunity.

Bears say

DexCom is a company in the continuous glucose monitoring space (CGM) that is facing intense competition, but still expects strong US growth and penetration into the Type 2 diabetes market in the future. While the company has seen improvements in margins and revenue growth, there are several risks that could potentially impact their performance, such as slower-than-expected adoption of their 15-day sensors or issues with their sales force. Their 2026 guidance was in line with expectations, but it remains to be seen if they can achieve the projected revenue growth and improve their profit margins.

DexCom (DXCM) has been analyzed by 21 analysts, with a consensus rating of Buy. 48% of analysts recommend a Strong Buy, 38% recommend Buy, 10% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DexCom and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DexCom (DXCM) Forecast

Analysts have given DexCom (DXCM) a Buy based on their latest research and market trends.

According to 21 analysts, DexCom (DXCM) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DexCom (DXCM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.